SCHEMBL23959794

SCHEMBL23959794

O=c1ccn2c(-c3ccc(F)cc3)nc3cccc1c32

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 1/20 0.44
POLB P06746 1/20 0.42
TNKS O95271 2/20 0.40
TNKS2 Q9H2K2 2/20 0.40
PARP2 Q9UGN5 2/20 0.40
MEN1 O00255 1/20 0.39
ATM Q13315 1/20 0.39
KCNH2 Q12809 2/20 0.39
GRM2 Q14416 2/20 0.39
MAPT P10636 1/20 0.38
CYP19A1 P11511 1/20 0.38
GRIA1 P42261 1/20 0.37
CACNG8 Q8WXS5 1/20 0.37
CACNG2 Q9Y698 1/20 0.37
TSHR P16473 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959772 0.87 TSHR (0.50) SMN1; SMN2KMT2AALDH1A1HPGDTNKS
SCHEMBL23959779 0.74 ALDH1A1 (0.52) KMT2AALDH1A1HPGDMEN1KDM4E
SCHEMBL23959788 0.74 KDM4E (0.53) SMN1; SMN2KMT2AALDH1A1HPGDPOLB
SCHEMBL23959843 0.70 ATM (0.42) ALDH1A1ATMGRM2TSHRKDM4E
SCHEMBL14161046 0.68 ADRA1A (0.55) SMN1; SMN2KMT2AALDH1A1HPGDPOLB
SCHEMBL4233293 0.68 KMT2A (0.79) SMN1; SMN2KMT2AALDH1A1HPGDPOLB
SCHEMBL23959783 0.65 CYP1A2 (0.44) SMN1; SMN2KMT2AALDH1A1HPGDPOLB
SCHEMBL31277320 0.64 KMT2A (0.70) KMT2AALDH1A1HPGDPOLBMEN1
SCHEMBL6200038 0.63 PARP1 (0.80)
SCHEMBL11482703 0.62 PAX8 (0.39) ALDH1A1HPGDPOLBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF HANGZHOU NORMAL UNIVERSITY 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332038-A1 6H-IMIDAZO[4,5,1-ij]QUINOLONE, SYNTHESIS METHOD AND USE THEREOF ABL1, KCNK4, KCNJ4 SMN1; SMN2 4559/4885KMT2A 866/4885ALDH1A1 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.